Vasculitis Foundation is located in Kansas City, MO. The organization was established in 1990. According to its NTEE Classification (E60) the organization is classified as: Health Support, under the broad grouping of Health Care and related organizations. As of 06/2023, Vasculitis Foundation employed 7 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Vasculitis Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2023, Vasculitis Foundation generated $3.2m in total revenue. This organization has experienced exceptional growth, as over the past 8 years, it has increased revenue by an average of 17.8% each year . All expenses for the organization totaled $1.3m during the year ending 06/2023. While expenses have increased by 3.9% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Vasculitis Foundation has awarded 49 individual grants totaling $1,751,394. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
BUILDING UPON THE COLLECTIVE STRENGTH OF THE VASCULITIS COMMUNITY, THE FOUNDATION SUPPORTS, INSPIRES AND EMPOWERS INDIVIDUALS WITH VASCULITIS AND THEIR FAMILIES THROUGH A WIDE RANGE OF EDUCATION, RESEARCH, CLINICAL, AND AWARENESS INITIATIVES. OUR VISION IS TO BE THE LEADING ORGANIZATION IN THE WORLD DEDICATED TO DIGANOSING, TREATING, AND CURING ALL FORMS OF VASCULITIS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
BUILDING UPON THE COLLECTIVE STRENGTH OF THE VASCULITIS COMMUNITY, THE VASCULITIS FOUNDATION (VF) SUPPORTS, INSPIRES, AND EMPOWERS INDIVIDUAL WITH VASCULITIS AND THEIR FAMILIES THROUGH A WIDE RANGE OF EDUCATION, RESEARCH, CLINICAL, AND AWARENESS INITIATIVES. OUR VISION IS TO BE THE LEADING ORGANIZATION IN THE WORLD DEDICATED TO DIAGNOSING, TREATING, AND CURING ALL FORMS OF VASCULITIS. THE VF PROVIDES SUPPORT THROUGH ITS EXTENSIVE WEBSITE, MONTLHY E-NEWSLETTERS, ELECTRONIC AND PRINTED EDUCATIONAL MATERIALS, PHONE AND EMAIL OUTREACH. WEBSITE VISITORS: 35,000 ANNUALLY; MONTHLY E-NEWSLETTER DISTRIBUTION: 10,000 SUBSCRIBERS; AND 3,500 PHONE AND EMAIL REQUESTS FOR ASSISTANCE THIS YEAR. THE VF OFFERS WIDE-RANGING LIVE AND ON-DEMAND WEBINARS AND PODCASTS THAT ADDRESS DISEASE SPOTLIGHTS, MENTAL HEALTH/WELLNESS, RESEARCH, THERAPIES AND TREATMENTS. THE VF HAD 120+ WEBINARS AND PODCASTS WITH 7,020 HOURS WATCHED, AND 150,000+ VIEWS ON VF'S YOUTUBE EDUCATION CHANNEL.
VASCULITIS - BUILDING OUTCOMES, LEADING DISCOVERIES (V-BOLD) PROGRAM COMBINES RESEARCH, FELLOWSHIPS, VASCULITIS CENTERS, AND THE VPPRN WITH THE GOAL TO IMPROVE THE QUALITY OF LIFE FOR PATIENTS WITH VASCULITIS, AND ULTIMATELY FIND THE CAUSE(S) AND CURE FOR VASCULITIS. RESEARCH: THE VF YOUNG INVESTIGATOR AWARD PROVIDES ONE OR TWO-YEAR GRANTS OF UP TO 50,000 TO SUPPORT RESEARCHERS WITHIN FIVE YEARS OF THE COMPLETION OF THEIR FELLOWSHIPS. THE FUNDING SUPPORTS PILOT STUDIES IN RESEARCHING DIAGNOSIS, ETIOLOGY/PATHOGENESIS, EPIDEMIOLOGY, AND TREATMENT/MANAGEMENT. FELLOWSHIPS: THE VF PARTNERS WITH ACADEMIC INSTITUTIONS AND THE VASCULITIS CLINICAL RESEARCH CONSORTIUM (VCRC) TO PROVIDE FELLOWSHIPS FOR PHYSICIAN- INVESTIGATORS WHO HAVE A STRONG INTEREST IN VASCULITIS. THIS MENTORED TRAINING PROGRAM EMPHASIZES CLINICAL, PATIENT-ORIENTED INVESTIGATION. VASCULITIS CENTERS ARE ESSENTIAL IN THE PATIENT JOURNEY - FROM DIAGNOSIS TO TREATMENT TO REMISSION, WITH THE POTENTIAL FOR CURES. VASCULITIS CENTERS PROVIDE COMPREHENSIVE, HIGH-QUALITY, AND COMPASSIONATE CARE TO PATIENTS WITH VASCULITIS. IN ADDITION, THEY HAVE THE CAPACITY TO ADVANCE OUR UNDERSTANDING OF VASCULITIS THROUGH RESEARCH. WITH EXPERTS IN THE MANAGEMENT AND STUDY OF THE DISEASE, VASCULITIS CENTERS ARE AT THE FOREFRONT OF SPECIALTY CARE AND CLINICAL RESEARCH, WHILE TREATING ALL TYPES OF VASCULITIS. VASCULITIS PATIENT-POWERED RESEARCH NETWORK (VPPRN) IS THE INTERNATIONAL RESEARCH NETWORK OF PATIENTS, SCIENTISTS, CLINICIANS, ADVOCATES AND FAMILY MEMBERS WHO WORK TO IMPROVE THE HEALTH CARE AND QUALITY OF LIFE FOR PEOPLE WITH VASCULITIS THROUGH HIGH-LEVEL CLINICAL RESEARCH. IN 2022-23, VF FUNDED SIX GRANTS TOTALLING 143,927.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Joyce A Kullman Executive Di | Officer | 40 | $99,642 |
Sara Baird Amodio President | OfficerTrustee | 4 | $0 |
Kevin Byram MD President-El | OfficerTrustee | 4 | $0 |
Suzanne Depaolis Past Preside | OfficerTrustee | 4 | $0 |
Don Nagle Treasurer | OfficerTrustee | 4 | $0 |
Nona Bear Secretary | OfficerTrustee | 4 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $3,847 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $2,884,364 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $2,888,211 |
Total Program Service Revenue | $275,281 |
Investment income | $84,580 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | -$615 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $3,247,457 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $113,750 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $30,177 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $119,336 |
Compensation of current officers, directors, key employees. | $15,514 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $340,774 |
Pension plan accruals and contributions | $9,293 |
Other employee benefits | $23,850 |
Payroll taxes | $31,912 |
Fees for services: Management | $0 |
Fees for services: Legal | $8,752 |
Fees for services: Accounting | $45,501 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $15,883 |
Fees for services: Other | $175,981 |
Advertising and promotion | $40,318 |
Office expenses | $53,236 |
Information technology | $134,246 |
Royalties | $0 |
Occupancy | $0 |
Travel | $67,894 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $70,741 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $4,390 |
Insurance | $4,211 |
All other expenses | $0 |
Total functional expenses | $1,290,245 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $139,006 |
Savings and temporary cash investments | $1,346,174 |
Pledges and grants receivable | $25,000 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $39,458 |
Net Land, buildings, and equipment | $8,117 |
Investments—publicly traded securities | $2,970,748 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $4,528,503 |
Accounts payable and accrued expenses | $3,455 |
Grants payable | $0 |
Deferred revenue | $45,100 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $34,207 |
Total liabilities | $82,762 |
Net assets without donor restrictions | $1,349,537 |
Net assets with donor restrictions | $3,096,204 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $4,528,503 |
Over the last fiscal year, Vasculitis Foundation has awarded $113,750 in support to 4 organizations.
Grant Recipient | Amount |
---|---|
OHIO STATE UNIVERSITY PURPOSE: VASCULITIS RESEARCH | $11,250 |
MAYO CLINIC PURPOSE: VASCULITIS RESEARCH | $20,000 |
TRUSTEES OF THE UNIVERSITY OF PA PURPOSE: VASCULITIS RESEARCH | $70,000 |
UNIVERSITY OF COLORADO DENVER PURPOSE: VASCULITIS RESEARCH | $12,500 |